Category: Respiratory

Theravance COPD drug clears safety study, setting up NDA

Theravance Biopharma and Mylan are still on course to file for approval of their nebulized chronic obstructive pulmonary disease (COPD) therapy in the fourth quarter after posting 12-month safety data. The trial suggests revefenacin has a tolerable safety profile comparable to that of Boehringer Ingelheim’s bronchodilator Spiriva. http://www.fiercebiotech.com/biotech/theravance-copd-drug-clears-safety-study-setting-up-nda

GOLD guidelines for the management of COPD – 2017 update

Chronic obstructive lung disease (COPD) is the third leading cause of death in the United States1 and a major cause of mortality and morbidity around the world. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released a new “2017 Report”2 with modified recommendations for the diagnosis, management, and prevention of COPD. The report contains […] http://www.pm360online.com/gold-guidelines-for-the-management-of-copd-2017-update/

Propeller Health, Novartis to Develop Add-On Sensor for Breezhaler

Propeller Health, a Madison, WI-based startup that makes Internet-connected inhalers and sensors designed to help asthma and chronic obstructive pulmonary disease (COPD) patients, says it is teaming up with Novartis to build an add-on sensor for the Swiss pharma giant’s Breezhaler device. The agreement, announced on Wednesday, is focused on patients with COPD who live […] http://www.xconomy.com/wisconsin/2017/02/08/propeller-health-novartis-to-develop-add-on-sensor-for-breezhaler/